COX-2-derived endocannabinoid metabolites as novel inflammatory mediators

Trends in Pharmacological Sciences

Volumn 35, Issue 6, 2014, Pages 284-292

  Alhouayek, Mireille ^a   Muccioli, Giulio G ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

anandamide; cannabinoid; FAAH; MAGL; prostaglandin synthase; prostanoid

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOCANNABINOID; ICOSANOID; PROSTAGLANDIN; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN G;

ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME REGULATION; HUMAN; INFLAMMATION; METABOLITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANANDAMIDE; CANNABINOID; FAAH; MAGL; PROSTAGLANDIN SYNTHASE; PROSTANOID;

ANIMALS; ARACHIDONIC ACIDS; CYCLOOXYGENASE 2; DINOPROSTONE; ENDOCANNABINOIDS; HUMANS; INFLAMMATION MEDIATORS; PROSTAGLANDINS G;

EID: 84901791811     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2014.03.001     Document Type: Review

References (79)

1. C. Nathan, and A. Ding Nonresolving inflammation Cell 140 2010 871 882
2. J.R. Ghilardi et al. Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia J. Neurosci. 24 2004 2727 2732 (Pubitemid 38380949)
3. W.L. Smith et al. Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis Chem. Rev. 111 2011 5821 5865
4. R. Rajakariar et al. COX-2 in inflammation and resolution Mol. Interv. 6 2006 199 207 (Pubitemid 44455202)
5. J.M. Ritter et al. Precaution, cyclooxygenase inhibition, and cardiovascular risk Trends Pharmacol. Sci. 30 2009 503 508
6. J.L. Wallace NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategies Br. J. Pharmacol. 165 2012 67 74
7. C.A. Rouzer, and L.J. Marnett Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways Chem. Rev. 111 2011 5899 5921
8. M. Yu et al. Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2 J. Biol. Chem. 272 1997 21181 21186 (Pubitemid 27373979)
9. K.R. Kozak et al. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2 J. Biol. Chem. 275 2000 33744 33749
10. K.R. Kozak et al. Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid 2-arachidonylglycerol J. Biol. Chem. 276 2001 30072 30077
11. K.R. Kozak et al. Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide Biochemistry 42 2003 9041 9049 (Pubitemid 36935412)
12. A.J. Vecchio, and M.G. Malkowski The structural basis of endocannabinoid oxygenation by cyclooxygenase-2 J. Biol. Chem. 286 2011 20736 20745
13. P. Pacher, and G. Kunos Modulating the endocannabinoid system in human health and disease - successes and failures FEBS J. 280 2013 1918 1943
14. M. Alhouayek et al. Controlling 2-arachidonoylglycerol metabolism as an anti-inflammatory strategy Drug Discov. Today 19 2014 295 304
15. C. Silvestri, and V. Di Marzo The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders Cell Metab. 17 2013 475 490
16. J.L. Blankman, and B.F. Cravatt Chemical probes of endocannabinoid metabolism Pharmacol. Rev. 65 2013 849 871
17. D.K. Nomura et al. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation Science 334 2011 809 813
18. J.E. Schlosburg et al. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system Nat. Neurosci. 13 2010 1113 1119
19. J.Z. Long et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects Nat. Chem. Biol. 5 2009 37 44
20. S.T. Glaser, and M. Kaczocha Cyclooxygenase-2 mediates anandamide metabolism in the mouse brain J. Pharmacol. Exp. Ther. 335 2010 380 388
21. J. Kim, and B.E. Alger Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus Nat. Neurosci. 7 2004 697 698 (Pubitemid 38859050)
22. A. Straiker et al. COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation Br. J. Pharmacol. 164 2011 1672 1683
23. H. Guhring et al. A role for endocannabinoids in indomethacin-induced spinal antinociception Eur. J. Pharmacol. 454 2002 153 163 (Pubitemid 35287474)
24. L.E. Staniaszek et al. Effects of COX-2 inhibition on spinal nociception: the role of endocannabinoids Br. J. Pharmacol. 160 2010 669 676
25. A. Telleria-Diaz et al. Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: involvement of prostaglandins and endocannabinoids Pain 148 2010 26 35
26. P. Bishay et al. R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids PLoS ONE 5 2010 e10628
27. K.C. Duggan et al. (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2 Nat. Chem. Biol. 7 2011 803 809
28. M. Alhouayek et al. Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6 Proc. Natl. Acad. Sci. U.S.A. 110 2013 17558 17563
29. D.J. Hermanson et al. Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation Nat. Neurosci. 16 2013 1291 1298
30. C.J. Fowler NSAIDs: eNdocannabinoid stimulating anti-inflammatory drugs? Trends Pharmacol. Sci. 33 2012 468 473
31. S. Oka et al. Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice J. Immunol. 177 2006 8796 8805 (Pubitemid 44893846)
32. D.C. McVey et al. Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1) J. Pharmacol. Exp. Ther. 304 2003 713 722 (Pubitemid 36152349)
33. J.K. Ritter et al. Production and actions of the anandamide metabolite prostamide E2 in the renal medulla J. Pharmacol. Exp. Ther. 342 2012 770 779
34. S.S. Hu et al. Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity Br. J. Pharmacol. 153 2008 1538 1549 (Pubitemid 351481525)
35. K.R. Kozak et al. Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo J. Biol. Chem. 276 2001 36993 36998
36. A. Vila et al. Hydrolysis of prostaglandin glycerol esters by the endocannabinoid-hydrolyzing enzymes, monoacylglycerol lipase and fatty acid amide hydrolase Biochemistry 46 2007 9578 9585 (Pubitemid 47291964)
37. C.J. Fowler, and G. Tiger Cyclooxygenation of the arachidonoyl side chain of 1-arachidonoylglycerol and related compounds block their ability to prevent anandamide and 2-oleoylglycerol metabolism by rat brain in vitro Biochem. Pharmacol. 69 2005 1241 1245 (Pubitemid 40417496)
38. D.F. Woodward et al. Recent progress in prostaglandin F2alpha ethanolamide (prostamide F2alpha) research and therapeutics Pharmacol. Rev. 65 2013 1135 1147
39. C.S. Nirodi et al. The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells Proc. Natl. Acad. Sci. U.S.A. 101 2004 1840 1845 (Pubitemid 38228978)
40. R. Richie-Jannetta et al. Structural determinants for calcium mobilization by prostaglandin E2 and prostaglandin F2alpha glyceryl esters in RAW 264.7 cells and H1819 cells Prostaglandins Other Lipid Mediat. 92 2010 19 24
41. L. Gatta et al. Discovery of prostamide F2alpha and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability PLoS ONE 7 2012 e31111
42. F. Correa et al. Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2) Biochem. J. 409 2008 761 770 (Pubitemid 351214202)
43. K.L. Brown et al. Characterisation of the prostaglandin E2-ethanolamide suppression of tumour necrosis factor-alpha production in human monocytic cells Biochim. Biophys. Acta 1831 2013 1098 1107
44. R.A. Ross et al. Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide J. Pharmacol. Exp. Ther. 301 2002 900 907 (Pubitemid 34595078)
45. H.A. Patsos et al. The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2 Gut 54 2005 1741 1750 (Pubitemid 41697674)
46. S. Valdeolivas et al. The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG Cell Death Dis. 4 2013 e862
47. P. Raman et al. 15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma Mol. Pharmacol. 80 2011 201 209
48. P. Raman et al. 15-Deoxy-delta(1)(2),(1)(4)-prostaglandin J(2)-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor gamma ligand, modulates nuclear factor of activated T cells J. Pharmacol. Exp. Ther. 342 2012 816 826
49. J.J. Prusakiewicz et al. Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid Biochemistry 48 2009 7353 7355
50. M.A. Windsor et al. Substrate-selective inhibition of cyclooxygenase-2: development and evaluation of achiral profen probes ACS Med. Chem. Lett. 3 2012 759 763
51. M. Cipriano et al. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen Eur. J. Pharmacol. 720 2013 383 390
52. D. Panikashvili et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury Nature 413 2001 527 531 (Pubitemid 32938751)
53. J. Zhang, and C. Chen Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation J. Biol. Chem. 283 2008 22601 22611
54. H. Du et al. Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-gamma Br. J. Pharmacol. 163 2011 1533 1549
55. C. Blazquez et al. Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease Brain 134 2011 119 136
56. D.W. Gilroy et al. Inducible cyclooxygenase may have anti-inflammatory properties Nat. Med. 5 1999 698 701 (Pubitemid 29289435)
57. T. Aoki, and S. Narumiya Prostaglandins and chronic inflammation Trends Pharmacol. Sci. 33 2012 304 311
58. D.F. Woodward et al. Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris Br. J. Pharmacol. 150 2007 342 352 (Pubitemid 46223451)
59. A. Ligresti et al. Prostamide F receptor antagonists with inhibitory activity at FAAH: a way to prevent the confounding effects of pro-inflammatory mediators formed following selective FAAH inhibition? Br. J. Pharmacol. 171 2014 1408 1419
60. L. Dong et al. Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer J. Biol. Chem. 286 2011 19035 19046
61. N.P. Sharma et al. Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acids Mol. Pharmacol. 77 2010 979 986
62. J. Claria, and C.N. Serhan Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions Proc. Natl. Acad. Sci. U.S.A. 92 1995 9475 9479
63. M.A. Windsor et al. Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib Bioorg. Med. Chem. Lett. 23 2013 5860 5864
64. K. Aritake et al. Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase J. Biol. Chem. 281 2006 15277 15286 (Pubitemid 43855117)
65. M.J. Stables, and D.W. Gilroy Old and new generation lipid mediators in acute inflammation and resolution Prog. Lipid Res. 50 2011 35 51
66. S.J. Craib et al. A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus Br. J. Pharmacol. 134 2001 30 37 (Pubitemid 32835465)
67. K. Starowicz et al. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism PLoS ONE 8 2013 e60040
68. K.R. Kozak et al. 15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist J. Biol. Chem. 277 2002 23278 23286 (Pubitemid 34952156)
69. N.T. Snider et al. A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist Mol. Pharmacol. 75 2009 965 972
70. J.K. Chen et al. Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors J. Biol. Chem. 283 2008 24514 24524
71. A.J. Hampson et al. Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor Biochim. Biophys. Acta 1259 1995 173 179
72. N. Ueda et al. Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist Biochim. Biophys. Acta 1254 1995 127 134
73. W.S. Edgemond et al. Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation Mol. Pharmacol. 54 1998 180 188 (Pubitemid 28337601)
74. K.R. Kozak et al. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides J. Biol. Chem. 277 2002 44877 44885 (Pubitemid 36159083)
75. A. Weber et al. Formation of prostamides from anandamide in FAAH knockout mice analyzed by HPLC with tandem mass spectrometry J. Lipid Res. 45 2004 757 763 (Pubitemid 38405683)
76. N. Koda et al. Synthesis of prostaglandin F ethanolamide by prostaglandin F synthase and identification of Bimatoprost as a potent inhibitor of the enzyme: new enzyme assay method using LC/ESI/MS Arch. Biochem. Biophys. 424 2004 128 136 (Pubitemid 38401945)
77. C. Silvestri et al. Anandamide-derived prostamide F2alpha negatively regulates adipogenesis J. Biol. Chem. 288 2013 23307 23321
78. J.S. Moody et al. Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase Biochemistry 40 2001 861 866 (Pubitemid 32108577)
79. C.A. Rouzer, and L.J. Marnett Glycerylprostaglandin synthesis by resident peritoneal macrophages in response to a zymosan stimulus J. Biol. Chem. 280 2005 26690 26700 (Pubitemid 41040701)